Effect of vitamin K on clotting factors in children with congenital cyanotic heart disease.
D000284:Administration, Oral; D000293:Adolescent; D001777:Blood Coagulation / Q000187:drug effects*; D001778:Blood Coagulation Disorders / Q000209:etiology; D001779:Blood Coagulation Factors / Q000032:analysis / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D003490:Cyanosis / Q000097:blood*; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D006330:Heart Defects, Congenital / Q000097:blood*; D006801:Humans; D007273:Injections, Intramuscular; D011516:Prothrombin / Q000032:analysis; D011517:Prothrombin Time; D014812:Vitamin K / Q000008:administration & dosage / Q000494:pharmacology*; D014813:Vitamin K Deficiency / Q000097:blood
D001779:Blood Coagulation Factors; D014812:Vitamin K; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin